Market Place
Sourcing Support
Osteal Therapeutics Announces Positive APEX Trial Results
14 Nov 2024 //
GLOBENEWSWIRE
Osteal Therapeutics Presents APEX Trial Results At MSIS Meeting
05 Aug 2024 //
GLOBENEWSWIRE
Osteal raises $50m to bring joint infection drug/device combo to market
06 Jun 2024 //
PHARMACEUTICAL TECHNOLOGY
Glucotrack: Implant Sustained Accuracy In 90-Day Preclinical Study
05 Jun 2024 //
GLOBENEWSWIRE
Osteal Therapeutics VT-X7 Receives FDA Breakthrough Therapy Designation
05 Dec 2023 //
GLOBENEWSWIRE
BioNTX Names Osteal Therapeutics 2023 Rising Star
28 Sep 2023 //
GLOBENEWSWIRE
Osteal Therapeutics Closes $23M Series C Financing
21 Sep 2023 //
GLOBENEWSWIRE
Osteal Announces First Subject Enrollment in Second Phase 2 Trial of VT-X7
07 Feb 2023 //
GLOBENEWSWIRE
Osteal Therapeutics Announces Leadership Team Appointments
29 Dec 2022 //
GLOBENEWSWIRE
Osteal Therapeutics,Completes Enrollment in APEX Phase 2 Clinical Trial of VT-X7
04 Nov 2022 //
GLOBENEWSWIRE
Osteal Tx Closes an Oversubscribed $30M Series B Financing
08 Mar 2022 //
GLOBENEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.